Result: HDAC-inhibition counteracts everolimus resistance in renal cell carcinoma in vitro by diminishing cdk2 and cyclin A

*Title*:

HDAC-inhibition counteracts everolimus resistance in renal cell carcinoma in vitro by diminishing cdk2 and cyclin A / Eva Juengel, Snigdha Nowaz, Jasmina Makarevi, Iyad Natsheh, Isabella Werner, Karen Nelson, Michael Reiter, Igor Tsaur, Jens Mani, Sebastian Harder, Georg Bartsch, Axel Haferkamp and Roman A. Blaheta

*Author/editor-in-chief*:

*Published in*:

Molecular cancer. - London : Biomed Central, 2002-. - Online-Ressource. - ISSN 1476-4598. - Band 13, Heft 152 (2014)
*show_all_articles*

*Manufacture*:

2014

*Physical description scale*:

Online-Ressource

*Format*:

*eArticle*

*Language*:

*eng*

*DOI*:

10.1186/1476-4598-13-152

*Result*: HDAC-inhibition counteracts everolimus resistance in renal cell carcinoma in vitro by diminishing cdk2 and cyclin A